Pacific Biosciences
(PACB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 30,358 | 38,205 | 18,844 | 38,063 | 23,058 |
| Marketable Securities | 36,486 | 44,667 | 83,510 | 77,684 | 40,433 |
| Receivables | 12,123 | 7,279 | 8,595 | 6,404 | 7,446 |
| Inventories | 17,404 | 19,650 | 17,878 | 19,694 | 23,440 |
| TOTAL | $98,909 | $112,588 | $131,659 | $143,873 | $96,412 |
| Non-Current Assets | |||||
| PPE Net | 33,457 | 33,613 | 34,073 | 34,490 | 36,103 |
| Other Non-Current Assets | 38,216 | 39,376 | 4,543 | 4,543 | 4,543 |
| TOTAL | $71,673 | $72,989 | $38,616 | $39,033 | $40,646 |
| Total Assets | $170,582 | $185,577 | $170,275 | $182,906 | $137,058 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,011 | 8,740 | 6,736 | 5,966 | 4,169 |
| Accrued Expenses | 14,107 | 11,158 | 12,823 | 9,298 | 10,935 |
| Other current liabilities | 1,764 | 312 | 788 | 645 | 744 |
| TOTAL | $49,453 | $45,097 | $26,884 | $21,649 | $22,264 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 14,659 | 14,384 | 14,121 |
| Deferred Revenues | 6,707 | 6,428 | 6,537 | 5,740 | 6,416 |
| Other Non-Current Liabilities | 43,921 | 44,861 | 16 | 13,977 | 14,146 |
| TOTAL | $45,375 | $45,630 | $29,330 | $29,377 | $29,320 |
| Total Liabilities | $94,828 | $90,727 | $56,214 | $51,026 | $51,584 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 152,965 | 152,675 | 150,960 | 148,902 | 131,942 |
| Common Shares | 153 | 153 | 150 | 149 | 132 |
| Retained earnings | -1,037,026 | -1,012,430 | -982,106 | -951,307 | -926,263 |
| Other shareholders' equity | 17 | 6 | -36 | -24 | -16 |
| TOTAL | $75,754 | $94,850 | $114,061 | $131,880 | $85,474 |
| Total Liabilities And Equity | $170,582 | $185,577 | $170,275 | $182,906 | $137,058 |